WhiteHorse Finance Earnings Call Transcripts
Fiscal Year 2025
-
Q4 2025 delivered higher net investment income and NAV, supported by accretive share repurchases and a strong distribution policy. Portfolio quality remained stable, though some credits face markdowns, and capital allocation is focused on buybacks and JV investments.
-
Q3 2025 saw declines in NII and NAV per share, driven by rate cuts, spread compression, and portfolio markdowns. The board reset the base distribution to $0.25/share, reduced the incentive fee, and approved a $15M share buyback. Non-accruals improved, but market competition and credit risks persist.
-
Q2 2025 saw a decline in portfolio value and net investment income, with NAV per share down 2.4% and non-accruals improving to 4.9%. Debt optimization and a new CLO reduced borrowing costs, while muted M&A activity and tariff uncertainty continue to impact deal flow.
-
Q1 2025 saw lower net investment income and a 1.6% NAV decline, driven by portfolio losses and higher non-accruals. The board is reviewing the dividend amid muted M&A activity and ongoing market volatility, while the JV continues to provide accretive returns.
Fiscal Year 2024
-
Q4 2024 saw lower net investment income and a 3.6% NAV per share decline, driven by portfolio markdowns and increased non-accruals. The company is focusing on non-sponsored lending and maintaining a stable dividend, while monitoring risks from tariffs and aggressive lending markets.
-
Q3 saw a decline in NAV and portfolio value due to company-specific losses, though net investment income exceeded the dividend. Aggressive market conditions and yield compression persist, prompting a strategic shift toward non-sponsor deals for better risk-return.
-
Q2 2024 saw softer results due to high repayments and portfolio markdowns, with NII of $9.3M and NAV per share down 0.4%. Non-accruals rose, notably Honors Holdings, while the company maintains a cautious approach amid aggressive market conditions and expects refinancing activity to remain high.